Skip to content
DU
Company

Updated:

DNIB UNWIND, INC.

DNIB UNWIND, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001385228, and its reported industry is...

Overview

DNIB UNWIND, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001385228, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-15, it reported annual revenue of USD 15,401,000; net income of USD -36,579,000; total assets of USD 50,742,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
DNIB UNWIND, INC.
Former names in filing history
BIND Therapeutics, Inc (2013-06-28 to 2016-08-01); BIND Biosciences, Inc (2013-02-08 to 2013-02-08); BIND Biosciences Inc (2006-12-15 to 2011-11-22)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Cambridge, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001385228

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalents
FY2015USD$15.4M-$36.6M$50.7M$24.7M
FY2014USD$10.4M-$32.5M$54.1M$19.3M
FY2013USD$10.9M-$27.7M$88.4M$51.6M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
8-KFORM 8-K
8-K8-K
8-K8-K
8-K8-K
8-KFORM 8-K
8-K8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-K8-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research DNIB UNWIND, INC. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

DNIB UNWIND, INC. | Cambridge Company | Altss